Overview
Kazutoshi Murata practices practicing medicine in Chiba, Japan.
Murata is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Cervical Cancer, PIK3CA-Related Overgrowth Spectrum, Esophageal Cancer, and Lung Metastases.
They are actively involved in clinical research, co-authoring 56 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazutoshi Murata
Is Kazutoshi Murata a top-rated expert for Cervical Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Kazutoshi Murata is classified as an Advanced expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazutoshi Murata participate in research or clinical trials?
Yes. Kazutoshi Murata has published 56 articles and abstracts on conditions like Cervical Cancer. You can view a list of Kazutoshi Murata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cervical CancerMurata isAdvanced. Learn about Cervical Cancer.
- Experienced
- Esophageal CancerMurata isExperienced. Learn about Esophageal Cancer.
- Lung MetastasesMurata isExperienced. Learn about Lung Metastases.
- PIK3CA-Related Overgrowth Spectrum